Professional use and authority
Assay-A provides B2B formulation decision-support, review records and product traceability tools. Use is restricted to authorised professional users acting for their organisation. You must be entitled to submit the products and records you manage. Account-type selection does not grant regulator or reviewer privileges.
Assay-A is not a medicine manufacturer or a government regulator. An Assay-A review, code or certificate is a platform record, not NAFDAC or FDA approval, a manufacturing licence, or a qualified-person batch release.
Customer responsibilities
Your organisation remains responsible for accurate registration details, source evidence, laboratory testing, GMP, product quality, lawful distribution and applicable regulatory requirements. Computational screens and draft reference limits must be checked against current authoritative sources before use.
Keep accounts individual and secure. Do not share passwords or sign for another person. Notify your organisation’s administrator of suspected misuse. Reviewers must disclose conflicts of interest and must not decide on their own workspace’s products.
Records and electronic acknowledgments
Submitting a signed action records the authenticated account, typed name, reason, agreement version, time and the affected record. A typed name expresses your intention to authorise that action; it is not an identity-document check or a qualified digital signature.
Records are retained for operational accountability and can be exported. Do not assume these tools alone meet 21 CFR Part 11, Nigerian evidentiary requirements or your organisation’s record-retention obligations. Those require separate assessment, procedures and, where applicable, validation.
Data, availability and access
You retain your rights in data you supply and permit its processing to operate the service, including scoped review and public verification disclosures described in the Privacy Notice. Do not upload patient-identifiable records or unrelated confidential information.
Access is subject to assigned permissions and appropriate use. Misuse may result in restriction through authorised administration. No uninterrupted availability, chemical-authenticity guarantee or regulatory outcome is promised. Plans currently operate without automated payment collection; any commercial agreement must be agreed separately.
Contract status and changes
This is a working legal draft for the current pilot, not a claim of legal compliance. The contracting entity, registered address, notice contact, applicable law, liability provisions and commercial terms must be finalised with counsel before broader deployment. A separately executed customer contract governs where it expressly overrides these terms.
A new agreement version requires a fresh acknowledgment before further authoritative actions. Questions or concerns should be raised with your Assay-A onboarding representative; no unverified legal contact address is published here.